SPPAM
WGS icon

Summit Partners Public Asset Management’s GeneDx Holdings WGS Stock Holding History

Summit Partners Public Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,900
Closed -$10.1M – 203
2025
Q4 		$10.1M Sell
77,900
-167,100
-68% -$22.9M 0.21% 90
2025
Q3 		$26.4M Buy
+245,000
New +$26.7M 0.55% 60

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Summit Partners Public Asset Management's WGS Position: Q1 2026 in Review

Summit Partners Public Asset Management reduced its GeneDx Holdings (WGS) stake by 48% in Q1 2026, selling an estimated $40.2M and leaving 479,418 shares worth $30.8M. The position accounts for 0.83% of the portfolio, ranked #42.

Summit Partners Public Asset Management first reported a position in WGS in Q3 2024 and has held it in 7 quarters since. The position peaked at $120M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Summit Partners Public Asset Management held 479,418 shares of GeneDx Holdings worth $30.8M as of Q1 2026.
  • Summit Partners Public Asset Management sold 441,169 GeneDx Holdings shares in Q1 2026, an estimated $40.2M.
  • GeneDx Holdings made up 0.83% of Summit Partners Public Asset Management's portfolio in Q1 2026, its #42 holding.
  • Summit Partners Public Asset Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 7 quarters since.
  • Summit Partners Public Asset Management's GeneDx Holdings position peaked at $120M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2026, filed 15 May 2026.